US Stock MarketDetailed Quotes

KRBP Kiromic BioPharma

Watchlist
  • 1.500
  • +0.020+1.35%
15min DelayClose Feb 14 16:00 ET
2.30MMarket Cap-0.24P/E (TTM)

Kiromic BioPharma Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
18.93%6.6M
47.99%6.35M
7.03%5.11M
-35.92%19.94M
-23.17%5.32M
-33.87%5.55M
-49.09%4.29M
-35.14%4.78M
22.95%31.11M
-32.38%6.92M
Selling and administrative expenses
-17.39%2.38M
-4.64%2.22M
-22.61%2.09M
-40.01%10.31M
-32.85%2.41M
-37.66%2.88M
-48.90%2.33M
-39.13%2.7M
23.36%17.19M
-47.93%3.59M
-General and administrative expense
-17.39%2.38M
-4.64%2.22M
-22.61%2.09M
-40.01%10.31M
-32.85%2.41M
-37.66%2.88M
-48.90%2.33M
-39.13%2.7M
23.36%17.19M
-47.93%3.59M
Research and development costs
57.94%4.23M
110.22%4.14M
45.64%3.02M
-30.86%9.62M
-12.73%2.91M
-29.26%2.68M
-49.31%1.97M
-29.08%2.08M
22.45%13.92M
-0.23%3.33M
Operating profit
-18.93%-6.6M
-47.99%-6.35M
-7.03%-5.11M
35.92%-19.94M
23.17%-5.32M
33.87%-5.55M
49.09%-4.29M
35.14%-4.78M
-22.95%-31.11M
32.38%-6.92M
Net non-operating interest income expense
-112.50%-935K
-36.52%-957K
-104.78%-1.07M
-1,012.43%-1.85M
-296.74%-633.2K
-31,328.57%-440K
-25,862.96%-701K
-18,578.57%-523K
-1,264.75%-166.5K
-2,605.08%-159.6K
Non-operating interest expense
112.50%935K
185.67%957K
141.22%1.07M
1,012.43%1.85M
296.74%633.2K
31,328.57%440K
12,307.41%335K
15,757.14%444K
1,264.75%166.5K
2,605.08%159.6K
Total other finance cost
----
----
----
----
----
----
--366K
--79K
----
----
Other net income (expense)
-94.27%103K
127.40%485K
36K
124.41%842.2K
9,737.50%1.26M
151.92%1.8M
-1.77M
-1,174.08%-3.45M
103.24%12.8K
Special income (charges)
--0
----
----
50.04%-1.73M
--0
101.16%40K
----
----
-968.17%-3.46M
--0
-Less:Other special charges
----
----
----
-50.04%1.73M
--0
-101.16%-40K
----
----
3,373.16%3.46M
--0
Other non- operating income (expenses)
-94.14%103K
127.40%485K
--36K
19,995.31%2.57M
--1.26M
--1.76M
---1.77M
----
-76.03%12.8K
----
Income before tax
-77.28%-7.44M
-0.90%-6.83M
-16.00%-6.15M
39.68%-20.95M
33.62%-4.69M
64.64%-4.19M
19.81%-6.76M
28.07%-5.3M
-35.73%-34.73M
33.54%-7.07M
Income tax
Net income
-77.28%-7.44M
-0.90%-6.83M
-16.00%-6.15M
39.68%-20.95M
33.62%-4.69M
64.64%-4.19M
19.81%-6.76M
28.07%-5.3M
-35.73%-34.73M
33.54%-7.07M
Net income continuous Operations
-77.28%-7.44M
-0.90%-6.83M
-16.00%-6.15M
39.68%-20.95M
33.62%-4.69M
64.64%-4.19M
19.81%-6.76M
28.07%-5.3M
-35.73%-34.73M
33.54%-7.07M
Minority interest income
Net income attributable to the parent company
-77.28%-7.44M
-0.90%-6.83M
-16.00%-6.15M
39.68%-20.95M
33.62%-4.69M
64.64%-4.19M
19.81%-6.76M
28.07%-5.3M
-35.73%-34.73M
33.54%-7.07M
Preferred stock dividends
Other preferred stock dividends
125.81%2.02M
152.58%1.52M
1,047.06%975K
639.62%2.55M
1,015.30%969.2K
929.92%895K
599.65%601K
-0.12%85K
55.32%344.8K
0.00%86.9K
Net income attributable to common stockholders
-85.83%-9.46M
-13.28%-8.34M
-32.27%-7.12M
33.00%-23.5M
20.88%-5.66M
57.40%-5.09M
13.57%-7.37M
27.75%-5.39M
-35.90%-35.08M
33.27%-7.15M
Basic earnings per share
57.24%-0.65
77.02%-0.74
83.79%-1
80.46%-12.59
62.49%-4.16
93.28%-1.52
80.18%-3.22
57.12%-6.17
5.00%-64.42
51.39%-11.09
Diluted earnings per share
57.24%-0.65
77.02%-0.74
83.79%-1
80.46%-12.59
62.49%-4.16
93.28%-1.52
80.18%-3.22
57.12%-6.17
5.00%-64.42
51.39%-11.09
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
--
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 18.93%6.6M47.99%6.35M7.03%5.11M-35.92%19.94M-23.17%5.32M-33.87%5.55M-49.09%4.29M-35.14%4.78M22.95%31.11M-32.38%6.92M
Selling and administrative expenses -17.39%2.38M-4.64%2.22M-22.61%2.09M-40.01%10.31M-32.85%2.41M-37.66%2.88M-48.90%2.33M-39.13%2.7M23.36%17.19M-47.93%3.59M
-General and administrative expense -17.39%2.38M-4.64%2.22M-22.61%2.09M-40.01%10.31M-32.85%2.41M-37.66%2.88M-48.90%2.33M-39.13%2.7M23.36%17.19M-47.93%3.59M
Research and development costs 57.94%4.23M110.22%4.14M45.64%3.02M-30.86%9.62M-12.73%2.91M-29.26%2.68M-49.31%1.97M-29.08%2.08M22.45%13.92M-0.23%3.33M
Operating profit -18.93%-6.6M-47.99%-6.35M-7.03%-5.11M35.92%-19.94M23.17%-5.32M33.87%-5.55M49.09%-4.29M35.14%-4.78M-22.95%-31.11M32.38%-6.92M
Net non-operating interest income expense -112.50%-935K-36.52%-957K-104.78%-1.07M-1,012.43%-1.85M-296.74%-633.2K-31,328.57%-440K-25,862.96%-701K-18,578.57%-523K-1,264.75%-166.5K-2,605.08%-159.6K
Non-operating interest expense 112.50%935K185.67%957K141.22%1.07M1,012.43%1.85M296.74%633.2K31,328.57%440K12,307.41%335K15,757.14%444K1,264.75%166.5K2,605.08%159.6K
Total other finance cost --------------------------366K--79K--------
Other net income (expense) -94.27%103K127.40%485K36K124.41%842.2K9,737.50%1.26M151.92%1.8M-1.77M-1,174.08%-3.45M103.24%12.8K
Special income (charges) --0--------50.04%-1.73M--0101.16%40K---------968.17%-3.46M--0
-Less:Other special charges -------------50.04%1.73M--0-101.16%-40K--------3,373.16%3.46M--0
Other non- operating income (expenses) -94.14%103K127.40%485K--36K19,995.31%2.57M--1.26M--1.76M---1.77M-----76.03%12.8K----
Income before tax -77.28%-7.44M-0.90%-6.83M-16.00%-6.15M39.68%-20.95M33.62%-4.69M64.64%-4.19M19.81%-6.76M28.07%-5.3M-35.73%-34.73M33.54%-7.07M
Income tax
Net income -77.28%-7.44M-0.90%-6.83M-16.00%-6.15M39.68%-20.95M33.62%-4.69M64.64%-4.19M19.81%-6.76M28.07%-5.3M-35.73%-34.73M33.54%-7.07M
Net income continuous Operations -77.28%-7.44M-0.90%-6.83M-16.00%-6.15M39.68%-20.95M33.62%-4.69M64.64%-4.19M19.81%-6.76M28.07%-5.3M-35.73%-34.73M33.54%-7.07M
Minority interest income
Net income attributable to the parent company -77.28%-7.44M-0.90%-6.83M-16.00%-6.15M39.68%-20.95M33.62%-4.69M64.64%-4.19M19.81%-6.76M28.07%-5.3M-35.73%-34.73M33.54%-7.07M
Preferred stock dividends
Other preferred stock dividends 125.81%2.02M152.58%1.52M1,047.06%975K639.62%2.55M1,015.30%969.2K929.92%895K599.65%601K-0.12%85K55.32%344.8K0.00%86.9K
Net income attributable to common stockholders -85.83%-9.46M-13.28%-8.34M-32.27%-7.12M33.00%-23.5M20.88%-5.66M57.40%-5.09M13.57%-7.37M27.75%-5.39M-35.90%-35.08M33.27%-7.15M
Basic earnings per share 57.24%-0.6577.02%-0.7483.79%-180.46%-12.5962.49%-4.1693.28%-1.5280.18%-3.2257.12%-6.175.00%-64.4251.39%-11.09
Diluted earnings per share 57.24%-0.6577.02%-0.7483.79%-180.46%-12.5962.49%-4.1693.28%-1.5280.18%-3.2257.12%-6.175.00%-64.4251.39%-11.09
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----------------Unqualified Opinion with Explanatory Notes--
Trending Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Symbol Mini Chart % Chg
Petroleo Brasileiro SA Petrobras
PBR
+4.45%
Strategy
MSTR
+3.94%
NVIDIA
NVDA
+2.63%
Vale SA
VALE
+1.99%
KB Home
KBH
+1.28%

Unlock the Full List